THROMBOLYTIC AGENTS FOR INTRAVASCULAR CLOTS

METHODS AND MATERIALS FOR USING FIBRIN SUPPORTS FOR RETINAL PIGMENT EPITHELIUM TRANSPLANTATION

ULTRASOUND-MEDIATED GENE THERAPY FOR DEEP VEIN THROMBOSIS AND POST-THROMBOTIC SYNDROME

E. COLI EXPRESSED RECOMBINANT HUMAN MICROPLASMIN, A PRODUCTION METHOD THEREOF, A PHARMACEUTICAL COMPOSITION AND A KIT COMPRISING THEREOF, A METHOD AND AN APPLICATION OF TREATING THROMBOEMBOLISM RELATED DISEASES BY USING THEREOF

COMPOSITIONS AND METHODS FOR TREATING VASCULAR DISEASE

METHOD FOR MANUFACTURING A MEDICAL PATCH FOR LOCAL AND CONTROLLED RELEASE OF BIOACTIVE SUBSTANCES FOR THE TREATMENT OF CHRONIC ULCERS, AND MEDICAL PATCH ACHIEVED WITH SUCH METHOD

MAGNETIC PARTICLE CONTROL AND VISUALIZATION

DEVICES FOR CONTROLLING MAGNETIC NANOPARTICLES TO TREAT FLUID OBSTRUCTIONS

WOUND HEALING

FUSION PROTEINS

METHOD AND DRUG FOR INCREASING NGF LEVEL

METHOD AND DRUG FOR INCREASING BDNF LEVEL

PREPARING AND USE OF GLU-PLASMINOGEN FROM BLOOD FRACTIONS

METHOD AND DRUG FOR PROMOTING DEGRADATION OF MISFOLDED PROTEIN AND AGGREGATE THEREOF

METHOD AND DRUG FOR TUMOR TREATMENT

Methods and materials for using fibrin supports for retinal pigment epithelium transplantation

METHOD AND DRUG FOR TREATING SPINAL MUSCULAR ATROPHY

METHOD AND DRUG FOR TREATING SPINAL MUSCULAR ATROPHY

METHOD AND DRUG FOR TREATING ALZHEIMER DISEASE

PLASMINOGEN FOR USE IN TREATING AND PREVENTING LUNG DYSFUNCTION

METHOD AND DRUG FOR TREATING PARKINSON'S DISEASE

METHOD AND MEDICINE FOR TREATING HUNTINGTON'S DISEASE

METHOD AND DRUG FOR PREVENTING AND TREATING ABNORMAL BLOOD PRESSURE CONDITION

METHOD AND DRUG FOR PREVENTING AND TREATING MULTIPLE SCLEROSIS

METHOD AND DRUG FOR TREATING VIRAL PNEUMONIA

Short in vivo half-life and in vivo unstable recombinant microplasmin, pharmaceutical composition comprising thereof and method of treating thromboembolism related diseases including administration thereof

Thrombolytic Agents for Intravascular Clots

METHOD AND MEDICINE FOR TREATING AMYOTROPHIC LATERAL SCLEROSIS

TUNEABLE DELIVERY OF NANOPARTICLE BOUND ACTIVE PLASMIN FOR THE TREATMENT OF THROMBOSIS

Fibrinolytic composition and method of its preparation

PLASMINOGEN FOR TREATING AND PREVENTING MICROTHROMBOSIS

Magnetic particle control and visualization

MEDICAL APPLICATION OF MUTANT PLASMINOGEN AND PLASMIN POLYPEPTIDE THERAPEUTICS

Plasminogen treatment of conditions associated with PAI-1 overexpression

DEVICES FOR CONTROLLING MAGNETIC NANOPARTICLES TO TREAT FLUID OBSTRUCTIONS

Method and drug for preventing or treating osteoarthritis

Pharmaceutical composition comprising plasminogen and uses thereof

Methods for diagnosing and treating Alzheimer's disease

NANOPARTICLES FOR SUSTAINED OPHTHALMIC DRUG DELIVERY AND METHODS OF USE

METHOD OF ENHANCING DELIVERY OF THERAPEUTIC COMPOUNDS TO THE EYE

Tuneable delivery of nanoparticle bound active plasmin for the treatment of thrombosis

Method for regulating and controlling GLP-1/GLP-1R and drug

Method for preventing and treating fatty liver

Method for treating coronary atherosclerosis and complications thereof

Methods and materials for using fibrin supports for retinal pigment epithelium transplantation

Pharmaceutical composition comprising plasminogen and uses thereof

Preparing and use of Glu-plasminogen from blood fractions

Method for preventing and treating tissue and organ fibrosis

DRUG FOR PREVENTING AND TREATING OSTEOPOROSIS AND USES THEREOF

METHOD FOR TREATING AND PREVENTING ATHEROSCLEROSIS AND COMPLICATIONS THEREOF

Method for mitigating heart disease

METHOD FOR PREVENTING AND TREATING LIPID METABOLISM DISORDERS AND RELATED DISEASES THEREOF

Method and drug for preventing and treating obesity

METHOD FOR PREVENTING AND TREATING DRUG-INDUCED RENAL INJURY

Method for preventing and treating pulmonary fibrosis

Method for preventing and treating liver fibrosis

METHOD FOR PREVENTING AND TREATING SKIN FIBROSIS

Method for promoting insulin secretion

NOVEL METHOD FOR TREATING DIABETES

Method for making glucagon and insulin restore normal balance

METHOD FOR PROMOTING EXPRESSION OF INSULIN RECEPTOR SUBSTRATE-2

Magnetic particle control and visualization

Plasminogen replacement therapy for plasminogen-deficiency

Use of serine protease inhibitors in the treatment of skin diseases

Method for preventing and treating cervical erosion

METHOD FOR PREVENTING OR TREATING LIVER TISSUE DAMAGE AND ASSOCIATED DISEASES

Method for preventing and treating angiocardiopathy

Method for preventing or treating radiation and chemical damage

Devices for controlling magnetic nanoparticles to treat fluid obstructions

Method of treating diabetic nephropathy comprising administering plasminogen

Treatment of diabetic nerve injury comprising administering plasminogen

DRUG TARGET FOR PREVENTING AND TREATING PERIODONTAL DISEASE, IMPROVING HEALING OF PERIODONTAL WOUNDS AND PROMOTING ORAL HEALTH

Method for preventing or treating diabetic retinopathy

PLASMINOGEN DOSAGE REGIMEN FOR WOUND HEALING

NANOPARTICLES FOR SUSTAINED OPHTHALMIC DRUG DELIVERY AND METHODS OF USE

Modified vaccinia virus strains for use in diagnostic and therapeutic methods

IMMOBILIZED PLASMINOGENASE COMPOSITION, PREPARATION PROCESS, USE AND DEVICE COMPRISING SUCH A COMPOSITION

Method of Enhancing Delivery of Therapeutic Compounds to the Eye

Pharmaceutical composition comprising plasminogen and uses thereof

Methods for diagnosing and treating Alzheimer's disease

Tuneable delivery of nanoparticle bound active plasmin for the treatment of thrombosis

Polymers having therapeutically active agents conjugated thereto, processes of preparing same and uses thereof

Magnetic particle control and visualization

Therapeutic magnetic control systems and contrast agents

MANAGEMENT OF TRACTIONAL MEMBRANES

Candidates against infection

Drug target for preventing and treating periodontal disease, improving healing of periodontal wounds and promoting oral health

Method of enhancing delivery of therapeutic compounds to the eye

METHODS FOR TREATMENT OF CORONARY HEART DISEASE EVENTS BASED ON LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 ACTIVITY

Modified vaccinia virus strains for use in diagnostic and therapeutic methods

Pharmacological vitreolysis

Polymers having therapeutically active agents conjugated thereto, processes of preparing same and uses thereof

USE OF SERINE PROTEASE INHIBITORS IN THE TREATMENT OF SKIN DISEASES

Management of Tractional Membranes

Plasminogen and plasmin variants

Method for treating filtration failure after trabeculectomy surgery

Methods for increasing plasmin activity and promoting plaque regression in the treatment of atherosclerosis

Pharmacological vitreolysis

Plasminogen and plasmin variants

PHARMACOLOGICAL VITREOLYSIS

Pharmacological vitreolysis

Reversibly inactivated acidified plasmin composition

PROTEASE ENZYMES FOR INCREASED PROTEIN DIGESTION RATE AND ABSORPTION AND METHODS OF USING THE SAME

Analgesic and anti-inflammatory composition

Methods and Compositions for Treating Conditions of the Eye

Devices for controlling magnetic nanoparticles to treat fluid obstructions

Methods of controlling magnetic nanoparticles to improve vascular flow

Magnetic-based methods for treating vessel obstructions

Magnetic-based systems for treating occluded vessels

IMPROVEMENT TO TRABECULECTOMY

Method of manufacturing fibrous hemostatic bandages

Variants of plasminogen and plasmin

Therapeutics And Methods For Treating Neoplastic Diseases Comprising Determining The Level Of Caveolin-1 And/Or Caveolin-2 In A Stromal Cell Sample

Pharmacological vitreolysis

Modified vaccinia virus strains for use in diagnostic and therapeutic methods

ANTIANGIOGENIC POLYPEPTIDES AND METHODS FOR INHIBITING ANGIOGENESIS

Pharmacological vitreolysis

METHODS AND COMPOSITIONS FOR USE OF ANGIOGENESIS INHIBITORS IN THE PREVENTION AND/OR CONTROL OF EPILEPSY

Methods and Compositions for Treating Conditions of the Eye

METHOD OF IMPROVING WOULD HEALING

Localized Chemical Lysis of Ocular Tissue

USE OF SERINE PROTEASE INHIBITORS IN THE TREATMENT OF SKIN DISEASES

Anticancer agent containing bl-angiostatin

STAGED IMMUNE-RESPONSE MODULATION IN ONCOLYTIC THERAPY

Methods for the treatment and prevention of diseases of biological conduits

Means and methods for the recruitment and identification of stem cells

Candidates against infection

Analgesic and anti-inflammatory composition

Recombinant plasmin for opthalmic indications

DRUG TARGET FOR PREVENTING AND TREATING PERIODONTAL DISEASE, IMPROVING HEALING OF PERIODONTAL WOUNDS AND PROMOTING ORAL HEALTH

Increasing NADPH-dependent products

Methods and Compositions for Treating Conditions of the Eye

Composition and method for preparing plasminogen

Methods for inhibiting VEGF-D

Modified vaccinia virus strains for use in diagnostic and therapeutic methods

Use of inactive-plasmin to treat chronic inflammatory disease and tumors

Method of Manufacturing Fibrous Hemostatic Bandages

Stabilized protease composition

Methods for attenuating virus strains for diagnostic and therapeutic uses

Pharmacological vitreolysis

Pharmacological vitreolysis

Modified vaccinia virus strains for use in diagnostic and therapeutic methods

Reversibly inactivated acidified plasmin

Use of Hyaluronidase in Combination with Plasmin for the Induction of Posterior Vitreous Detachment

ANTIANGIOGENIC POLYPEPTIDES AND METHODS FOR INHIBITING ANGIOGENESIS

USE OF A VECTOR COMPRISING A NUCLEIC ACID ENCODING AN ANTI-ANGIOGENIC FACTOR FOR THE TREATMENT OF CORNEAL NEOVASCULARIZATION

Pharmacological vitreolysis

Method of promoting healing of a tympanic membrane perforation using plasminogen

Pharmaceutical Composition Comprising Factor VII Polypeptides and TAFI Polypeptides

Pharmacological vitreolysis

Combination of a growth factor and a protease enzyme

Method for inhibiting apoptosis through the p75 neurotrophin receptor

Non-Surgical Method for Preventing or Reducing the Rate of the Progression of Non-Proliferative Diabetic Retinopathy and the Treatment of Other Ocular Conditions

METHODS AND COMPOSITIONS FOR USE OF ANGIOGENESIS INHIBITORS IN THE PREVENTION AND/OR CONTROL OF EPILEPSY

Pharmaceutical combined preparation containing a therapeutic protein

B7-H4 expression on tumor vasculature

Compositions and Methods for Effecting Controlled Posterior Vitreous Detachment

Compositions and Methods for Effecting Controlled Posterior Vitreous Detachment

Non-Surgical Method for Preventing or Reducing the Rate of the Progression of Non-Proliferative Diabetic Retinopathy and the Treatment of Other Ocular Conditions

Methods for the treatment and prevention of diseases of biological conduits

Non-Surgical Method for Preventing or Reducing the Rate of the Progression of Non-Proliferative Diabetic Retinopathy and the Treatment of Other Ocular Conditions

Method of accelerating wound healing by administration of plasminogen

Inhibition of tumor angiogenesis by combination of thrombospondin-1 and inhibitors of vascular endothelial growth factor

Non-surgical method for preventing or reducing the rate of the progression of non-proliferative diabetic retinopathy and the treatment of other ocular conditions

Method and composition for preventing or reducing edema, deep vein thrombosis and/or pulmonary embolism

Means and methods for the recruitment and identification of stem cells

Compositions for gene therapy of rheumatoid arthritis including a gene encoding an anti-angiogenic protein or parts thereof

Compositions for gene therapy of rheumatoid arthritis including a gene encoding an anti-angiogenic protein or parts thereof

Raav vector compositions and methods for the treatment of choroidal neovascularization

Analgesic and anti-inflammatory composition

Treatment and diagnosis of infertitlity using TGFbeta or activin

Plasminogen fragment having activity to inhibit tumor metastasis and growth and process for preparing same technical field

Compositions and methods for enhancing structural and functional nervous system reorganization and recovery

Composition and method for repairing nerve damage and enhancing functional recovery of nerve

Methods and compositions for activating VEGF-D and VEGF-C

Compositions for gene therapy of rheumatoid arthritis including a gene encoding an anti-angiogenic protein or parts thereof

Tumor treating combinations, compositions and methods

Compounds useful in inhibiting vascular leakage, inflammation and fibrosis and methods of making and using same

Methods for inhibiting vascular permeability

Agent for inducing or inhibiting an angiogenesis

Compounds useful in inhibiting vascular leakage, inflammation and fibrosis and methods of making and using same

Pharmacological vitreolysis

Methods for inhibiting vascular permeability

TGF-beta activation and use

Histidine-rich glycoprotein